Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Melphalan flufenamide

EU orphan designation number: EU/3/15/1463   
Active ingredient: Melphalan flufenamide
Indication: Treatment of plasma cell myeloma
Sponsor: Oncopeptides AB
Västra Trädgårdsgatan 15, SE-111 53 Stockholm, Sverige

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
23/03/2015 Orphan designation EMA/OD/293/14 (2015)2032 of 19/03/2015